Omega-3 fatty acid supplementation, pro-resolving mediators, and clinical outcomes in maternal-infant pairs

Tara M. Nordgren, Ann Anderson Berry, Matthew Van Ormer, Samuel Zoucha, Elizabeth Elliott, Rebecca Johnson, Elizabeth McGinn, Caleb Cave, Katherine Rilett, Kara Weishaar, Sai Sujana Maddipati, Harriet Appeah, Corrine K Hanson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Omega (n)-3 fatty acids are vital to neonatal maturation, and recent investigations reveal n-3 fatty acids serve as substrates for the biosynthesis of specialized pro-resolving lipid mediators (SPM) that have anti-inflammatory and immune-stimulating effects. The role SPM play in the protection against negative maternal-fetal health outcomes is unclear, and there are no current biomarkers of n-3 fatty acid sufficiency. We sought to ascertain the relationships between n-3 fatty acid intake, SPM levels, and maternal-fetal health outcomes. We obtained n-3 fatty acid intake information from 136 mothers admitted for delivery using a food frequency questionnaire and measured docosahexaenoic acid (DHA)-derived SPMs resolvin D1 (RvD1) and RvD2 in maternal and cord plasma. We found significantly elevated SPM in maternal versus cord plasma, and increased SPM levels were associated with at-risk outcomes. We also identified that increased DHA intake was associated with elevated maternal plasma RvD1 (p = 0.03; R 2 = 0.18) and RvD2 (p = 0.04; R 2 = 0.20) in the setting of neonatal intensive care unit (NICU) admission. These findings indicate that increased n-3 fatty acid intake may provide increased substrate for the production of SPM during high-risk pregnancy/delivery conditions, and that increased maternal plasma SPM could serve as a biomarker for negative neonatal outcomes.

Original languageEnglish (US)
Article number98
JournalNutrients
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Omega-3 Fatty Acids
omega-3 fatty acids
Mothers
Lipids
lipids
Docosahexaenoic Acids
docosahexaenoic acid
biomarkers
Biomarkers
High-Risk Pregnancy
Neonatal Intensive Care Units
food frequency questionnaires
Anti-Inflammatory Agents
pregnancy
biosynthesis
Food

Keywords

  • Docosahexaenoic acid (DHA)
  • Fetal health
  • Omega-3 fatty acid
  • Pregnancy
  • Resolvins
  • Specialized pro-resolving lipid mediator (SPM)

ASJC Scopus subject areas

  • Food Science
  • Nutrition and Dietetics

Cite this

Omega-3 fatty acid supplementation, pro-resolving mediators, and clinical outcomes in maternal-infant pairs. / Nordgren, Tara M.; Berry, Ann Anderson; Van Ormer, Matthew; Zoucha, Samuel; Elliott, Elizabeth; Johnson, Rebecca; McGinn, Elizabeth; Cave, Caleb; Rilett, Katherine; Weishaar, Kara; Maddipati, Sai Sujana; Appeah, Harriet; Hanson, Corrine K.

In: Nutrients, Vol. 11, No. 1, 98, 01.01.2019.

Research output: Contribution to journalArticle

Nordgren, TM, Berry, AA, Van Ormer, M, Zoucha, S, Elliott, E, Johnson, R, McGinn, E, Cave, C, Rilett, K, Weishaar, K, Maddipati, SS, Appeah, H & Hanson, CK 2019, 'Omega-3 fatty acid supplementation, pro-resolving mediators, and clinical outcomes in maternal-infant pairs', Nutrients, vol. 11, no. 1, 98. https://doi.org/10.3390/nu11010098
Nordgren TM, Berry AA, Van Ormer M, Zoucha S, Elliott E, Johnson R et al. Omega-3 fatty acid supplementation, pro-resolving mediators, and clinical outcomes in maternal-infant pairs. Nutrients. 2019 Jan 1;11(1). 98. https://doi.org/10.3390/nu11010098
Nordgren, Tara M. ; Berry, Ann Anderson ; Van Ormer, Matthew ; Zoucha, Samuel ; Elliott, Elizabeth ; Johnson, Rebecca ; McGinn, Elizabeth ; Cave, Caleb ; Rilett, Katherine ; Weishaar, Kara ; Maddipati, Sai Sujana ; Appeah, Harriet ; Hanson, Corrine K. / Omega-3 fatty acid supplementation, pro-resolving mediators, and clinical outcomes in maternal-infant pairs. In: Nutrients. 2019 ; Vol. 11, No. 1.
@article{eb83a4a821c343d1bef04caace2f82a1,
title = "Omega-3 fatty acid supplementation, pro-resolving mediators, and clinical outcomes in maternal-infant pairs",
abstract = "Omega (n)-3 fatty acids are vital to neonatal maturation, and recent investigations reveal n-3 fatty acids serve as substrates for the biosynthesis of specialized pro-resolving lipid mediators (SPM) that have anti-inflammatory and immune-stimulating effects. The role SPM play in the protection against negative maternal-fetal health outcomes is unclear, and there are no current biomarkers of n-3 fatty acid sufficiency. We sought to ascertain the relationships between n-3 fatty acid intake, SPM levels, and maternal-fetal health outcomes. We obtained n-3 fatty acid intake information from 136 mothers admitted for delivery using a food frequency questionnaire and measured docosahexaenoic acid (DHA)-derived SPMs resolvin D1 (RvD1) and RvD2 in maternal and cord plasma. We found significantly elevated SPM in maternal versus cord plasma, and increased SPM levels were associated with at-risk outcomes. We also identified that increased DHA intake was associated with elevated maternal plasma RvD1 (p = 0.03; R 2 = 0.18) and RvD2 (p = 0.04; R 2 = 0.20) in the setting of neonatal intensive care unit (NICU) admission. These findings indicate that increased n-3 fatty acid intake may provide increased substrate for the production of SPM during high-risk pregnancy/delivery conditions, and that increased maternal plasma SPM could serve as a biomarker for negative neonatal outcomes.",
keywords = "Docosahexaenoic acid (DHA), Fetal health, Omega-3 fatty acid, Pregnancy, Resolvins, Specialized pro-resolving lipid mediator (SPM)",
author = "Nordgren, {Tara M.} and Berry, {Ann Anderson} and {Van Ormer}, Matthew and Samuel Zoucha and Elizabeth Elliott and Rebecca Johnson and Elizabeth McGinn and Caleb Cave and Katherine Rilett and Kara Weishaar and Maddipati, {Sai Sujana} and Harriet Appeah and Hanson, {Corrine K}",
year = "2019",
month = "1",
day = "1",
doi = "10.3390/nu11010098",
language = "English (US)",
volume = "11",
journal = "Nutrients",
issn = "2072-6643",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "1",

}

TY - JOUR

T1 - Omega-3 fatty acid supplementation, pro-resolving mediators, and clinical outcomes in maternal-infant pairs

AU - Nordgren, Tara M.

AU - Berry, Ann Anderson

AU - Van Ormer, Matthew

AU - Zoucha, Samuel

AU - Elliott, Elizabeth

AU - Johnson, Rebecca

AU - McGinn, Elizabeth

AU - Cave, Caleb

AU - Rilett, Katherine

AU - Weishaar, Kara

AU - Maddipati, Sai Sujana

AU - Appeah, Harriet

AU - Hanson, Corrine K

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Omega (n)-3 fatty acids are vital to neonatal maturation, and recent investigations reveal n-3 fatty acids serve as substrates for the biosynthesis of specialized pro-resolving lipid mediators (SPM) that have anti-inflammatory and immune-stimulating effects. The role SPM play in the protection against negative maternal-fetal health outcomes is unclear, and there are no current biomarkers of n-3 fatty acid sufficiency. We sought to ascertain the relationships between n-3 fatty acid intake, SPM levels, and maternal-fetal health outcomes. We obtained n-3 fatty acid intake information from 136 mothers admitted for delivery using a food frequency questionnaire and measured docosahexaenoic acid (DHA)-derived SPMs resolvin D1 (RvD1) and RvD2 in maternal and cord plasma. We found significantly elevated SPM in maternal versus cord plasma, and increased SPM levels were associated with at-risk outcomes. We also identified that increased DHA intake was associated with elevated maternal plasma RvD1 (p = 0.03; R 2 = 0.18) and RvD2 (p = 0.04; R 2 = 0.20) in the setting of neonatal intensive care unit (NICU) admission. These findings indicate that increased n-3 fatty acid intake may provide increased substrate for the production of SPM during high-risk pregnancy/delivery conditions, and that increased maternal plasma SPM could serve as a biomarker for negative neonatal outcomes.

AB - Omega (n)-3 fatty acids are vital to neonatal maturation, and recent investigations reveal n-3 fatty acids serve as substrates for the biosynthesis of specialized pro-resolving lipid mediators (SPM) that have anti-inflammatory and immune-stimulating effects. The role SPM play in the protection against negative maternal-fetal health outcomes is unclear, and there are no current biomarkers of n-3 fatty acid sufficiency. We sought to ascertain the relationships between n-3 fatty acid intake, SPM levels, and maternal-fetal health outcomes. We obtained n-3 fatty acid intake information from 136 mothers admitted for delivery using a food frequency questionnaire and measured docosahexaenoic acid (DHA)-derived SPMs resolvin D1 (RvD1) and RvD2 in maternal and cord plasma. We found significantly elevated SPM in maternal versus cord plasma, and increased SPM levels were associated with at-risk outcomes. We also identified that increased DHA intake was associated with elevated maternal plasma RvD1 (p = 0.03; R 2 = 0.18) and RvD2 (p = 0.04; R 2 = 0.20) in the setting of neonatal intensive care unit (NICU) admission. These findings indicate that increased n-3 fatty acid intake may provide increased substrate for the production of SPM during high-risk pregnancy/delivery conditions, and that increased maternal plasma SPM could serve as a biomarker for negative neonatal outcomes.

KW - Docosahexaenoic acid (DHA)

KW - Fetal health

KW - Omega-3 fatty acid

KW - Pregnancy

KW - Resolvins

KW - Specialized pro-resolving lipid mediator (SPM)

UR - http://www.scopus.com/inward/record.url?scp=85059627875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059627875&partnerID=8YFLogxK

U2 - 10.3390/nu11010098

DO - 10.3390/nu11010098

M3 - Article

C2 - 30621269

AN - SCOPUS:85059627875

VL - 11

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 1

M1 - 98

ER -